NFKB1 and COVID-19: However, a few reports have indicated that PPARβ/δ suppressing transcription factors involved in the inflammatory response, including NF-κB and AP-1 (31), reduce the expression levels of GDF-15 (one of the inflammatory biomarkers of COVID-19 severity) in a negative feedback manner (174).